Mechlorethamine.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    ASHP Patient Medication Information - English Version. Mar2022, p1-1. 1p.
  • Additional Information
    • Abstract:
      Mechlorethamine is used to treat Hodgkin's lymphoma (Hodgkin's disease) and certain types of non-Hodgkin's lymphoma (types of cancer that begin in a type of white blood cells that normally fights infection); mycosis fungoides (a type of cancer of the immune system that first appear as skin rashes); certain types of leukemia (cancer of the white blood cells), including chronic lymphocytic leukemia (CLL) and chronic myelogenous leukemia (CML); and lung cancer. Mechlorethamine is also used to treat polycythemia vera (a disease in which too many red blood cells are made in the bone marrow). It is also used to treat malignant effusions (a condition when fluid collects in the lungs or around the heart) that are caused by cancerous tumors. Mechlorethamine is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body. [ABSTRACT FROM PUBLISHER]
    • Abstract:
      Copyright of ASHP Patient Medication Information - English Version is the property of American Society of Health System Pharmacists and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
HoldingsOnline